Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond

Translational Research - Tập 159 - Trang 127-139 - 2012
Chris T. Longenecker1,2, Brian D. Hoit1,2
1Harrington-McLaughlin Heart and Vascular Institute, University Hospitals Case Medical Center, Cleveland, Ohio
2Case Western Reserve University, Cleveland, Ohio

Tài liệu tham khảo

Libby, 2009, Inflammation in atherosclerosis: from pathophysiology to practice, J Am Coll Cardiol, 54, 2129, 10.1016/j.jacc.2009.09.009 Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646 Henry, 1998, Severe premature coronary artery disease with protease inhibitors, Lancet, 351, 1328, 10.1016/S0140-6736(05)79053-X Bots, 1997, Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study, Circulation, 96, 1432, 10.1161/01.CIR.96.5.1432 Chambless, 1997, Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993, Am J Epidemiol, 146, 483, 10.1093/oxfordjournals.aje.a009302 O'Leary, 1999, Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group, N Engl J Med, 340, 14, 10.1056/NEJM199901073400103 Pignoli, 1986, Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging, Circulation, 74, 1399, 10.1161/01.CIR.74.6.1399 Stein, 2008, J Am Soc Echocardiogr, 21, 93, 10.1016/j.echo.2007.11.011 Makris, 2011, Three-dimensional ultrasound imaging for the evaluation of carotid atherosclerosis, Atherosclerosis, 10.1016/j.atherosclerosis.2011.05.006 Hulten, 2009, HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies, Heart, 95, 1826, 10.1136/hrt.2009.177774 Hsue, 2004, Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection, Circulation, 109, 1603, 10.1161/01.CIR.0000124480.32233.8A Currier, 2007, Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults, AIDS, 21, 1137, 10.1097/QAD.0b013e32811ebf79 Mercie, 2005, Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients, HIV Med, 6, 380, 10.1111/j.1468-1293.2005.00324.x Hsue, 2006, Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses, AIDS, 20, 2275, 10.1097/QAD.0b013e3280108704 Kaplan, 2011, T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women, J Infect Dis, 203, 452, 10.1093/infdis/jiq071 El-Sadr, 2006, CD4+ count-guided interruption of antiretroviral treatment, N Engl J Med, 355, 2283, 10.1056/NEJMoa062360 Friis-Moller, 2007, Class of antiretroviral drugs and the risk of myocardial infarction, N Engl J Med, 356, 1723, 10.1056/NEJMoa062744 Jang, 2011, Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus, Atherosclerosis, 217, 514, 10.1016/j.atherosclerosis.2011.03.035 Lo, 2010, Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men, AIDS, 24, 243, 10.1097/QAD.0b013e328333ea9e Guaraldi, 2011, Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients, AIDS, 25, 1199, 10.1097/QAD.0b013e3283474b9f Falcone, 2011, Framingham risk score and early markers of atherosclerosis in a cohort of adults infected with HIV, Antivir Ther, 16, 1, 10.3851/IMP1682 Fitch, 2010, Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters, J Acquir Immune Defic Syndr, 55, 495, 10.1097/QAI.0b013e3181edab0b Crum-Cianflone, 2011, Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons(∗), HIV Med, 12, 463, 10.1111/j.1468-1293.2010.00904.x Burdo, 2011, Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients, J Infect Dis, 204, 1227, 10.1093/infdis/jir520 Bischoff, 2010, Comparison of sequential and helical scanning for radiation dose and image quality: results of the prospective multicenter study on radiation dose estimates of cardiac CT angiography (PROTECTION) I Study, AJR Am J Roentgenol, 194, 1495, 10.2214/AJR.09.3543 Achenbach, 2010, Coronary computed tomography angiography with a consistent dose below 1 mSv using prospectively electrocardiogram-triggered high-pitch spiral acquisition, Eur Heart J, 31, 340, 10.1093/eurheartj/ehp470 Sakuma, 2011, Coronary CT versus MR angiography: the role of MR angiography, Radiology, 258, 340, 10.1148/radiol.10100116 Kramer, 2009, Peripheral MR angiography, Magn Reson Imaging Clin N Am, 17, 91, 10.1016/j.mric.2008.12.006 Mostardi, 2011, High spatial and temporal resolution imaging of the arterial vasculature of the lower extremity with contrast enhanced MR angiography, Clin Anat, 24, 478, 10.1002/ca.21124 Blackham, 2011, Applications of time-resolved MR angiography, AJR Am J Roentgenol, 196, W613, 10.2214/AJR.10.4227 Floris-Moore, 2009, Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging, AIDS, 23, 941, 10.1097/QAD.0b013e328329c76b Yonemura, 2005, Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging, J Am Coll Cardiol, 45, 733, 10.1016/j.jacc.2004.11.039 Corti, 2005, Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging, J Am Coll Cardiol, 46, 106, 10.1016/j.jacc.2005.03.054 Ding, 2009, The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA), Am J Clin Nutr, 90, 499, 10.3945/ajcn.2008.27358 Iacobellis, 2007, Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus, Am J Cardiol, 99, 1470, 10.1016/j.amjcard.2006.12.082 Iacobellis, 2007, Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome, Curr HIV Res, 5, 275, 10.2174/157016207780077084 Lo, 2010, Increased epicardial adipose tissue volume in HIV-infected men and relationships to body composition and metabolic parameters, AIDS, 24, 2127, 10.1097/QAD.0b013e32833c055a Faulx, 2003, Detection of endothelial dysfunction with brachial artery ultrasound scanning, Am Heart J, 145, 943, 10.1016/S0002-8703(03)00097-8 Fathi, 2004, The relative importance of vascular structure and function in predicting cardiovascular events, J Am Coll Cardiol, 43, 616, 10.1016/j.jacc.2003.09.042 Yeboah, 2009, Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis, Circulation, 120, 502, 10.1161/CIRCULATIONAHA.109.864801 Corretti, 2002, Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force, J Am Coll Cardiol, 39, 257, 10.1016/S0735-1097(01)01746-6 Solages, 2006, Endothelial function in HIV-infected persons, Clin Infect Dis, 42, 1325, 10.1086/503261 Blum, 2005, Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction, Clin Cardiol, 28, 149, 10.1002/clc.4960280311 Torriani, 2008, Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s, J Am Coll Cardiol, 52, 569, 10.1016/j.jacc.2008.04.049 Vernon, 2011, A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults, AIDS Res Hum Retroviruses, 10.1089/aid.2010.0320 Longenecker C, Hileman C, Carman T, et al. Vitamin D supplementation and endothelial function among vitamin D-deficient HIV-infected persons: a randomized placebo-controlled trial. 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2011. Stein, 2001, Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction, Circulation, 104, 257, 10.1161/01.CIR.104.3.257 Murphy, 2010, Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy, AIDS, 24, 885, 10.1097/QAD.0b013e3283352ed5 Flammer, 2009, Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial, Heart, 95, 385, 10.1136/hrt.2007.137646 Hurlimann, 2006, Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial, Heart, 92, 110, 10.1136/hrt.2004.056523 Chow, 2010, Short-term effects of extended-release niacin on endothelial function in HIV-infected patients on stable antiretroviral therapy, AIDS, 24, 1019, 10.1097/QAD.0b013e3283383016 Gupta, 2010, Anti-inflammatory treatment with pentoxifylline improves HIV-related endothelial dysfunction: a pilot study, AIDS, 24, 1377, 10.1097/QAD.0b013e3283396024 Gupta, 2008, Improvement in HIV-related endothelial dysfunction using the anti-inflammatory agent salsalate: a pilot study, AIDS, 22, 653, 10.1097/QAD.0b013e3282f470d2 Hileman, 2010, Salsalate is poorly tolerated and fails to improve endothelial function in virologically suppressed HIV-infected adults, AIDS, 24, 1958, 10.1097/QAD.0b013e32833c3251 Hendel, 2009, J Am Coll Cardiol, 53, 2201, 10.1016/j.jacc.2009.02.013 Catzin-Kuhlmann, 2007, Human immunodeficiency virus-infected subjects have no altered myocardial perfusion, Int J Cardiol, 122, 90, 10.1016/j.ijcard.2006.11.040 Lebech, 2008, Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia, Eur J Nucl Med Mol Imaging, 35, 2049, 10.1007/s00259-008-0846-6 Kristoffersen, 2010, Reduction in coronary and peripheral vasomotor function in patients with HIV after initiation of antiretroviral therapy: a longitudinal study with positron emission tomography and flow-mediated dilation, Nucl Med Commun, 31, 874, 10.1097/MNM.0b013e32833d82e6 Vaccarino, 2011, Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins, J Am Coll Cardiol, 57, 1271, 10.1016/j.jacc.2010.09.074 Ishimori, 2011, Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus, JACC Cardiovasc Imaging, 4, 27, 10.1016/j.jcmg.2010.09.019 Weber, 2004, Arterial stiffness, wave reflections, and the risk of coronary artery disease, Circulation, 109, 184, 10.1161/01.CIR.0000105767.94169.E3 Laurent, 2001, Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients, Hypertension, 37, 1236, 10.1161/01.HYP.37.5.1236 van Vonderen, 2009, Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy, J Acquir Immune Defic Syndr, 50, 153, 10.1097/QAI.0b013e31819367cd Seaberg, 2010, Association between human immunodeficiency virus infection and stiffness of the common carotid artery, Stroke, 41, 2163, 10.1161/STROKEAHA.110.583856 Schillaci, 2005, Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection, Arterioscler Thromb Vasc Biol, 25, 2381, 10.1161/01.ATV.0000183744.38509.de Baker, 2009, Untreated HIV infection and large and small artery elasticity, J Acquir Immune Defic Syndr, 52, 25, 10.1097/QAI.0b013e3181b02e6a Schillaci, 2008, Aortic stiffness in untreated adult patients with human immunodeficiency virus infection, Hypertension, 52, 308, 10.1161/HYPERTENSIONAHA.108.114660 Lazar, 2009, Arterial wave reflection in HIV-infected and HIV-uninfected Rwandan women, AIDS Res Hum Retroviruses, 25, 877, 10.1089/aid.2008.0269 Ho, 2010, Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals, AIDS, 24, 1897, 10.1097/QAD.0b013e32833bee44 Boccara, 2006, Influence of pravastatin on carotid artery structure and function in dyslipidemic HIV-infected patients receiving antiretroviral therapy, AIDS, 20, 2395, 10.1097/QAD.0b013e32801120e3 Kaplan, 2011, T cell activation predicts carotid artery stiffness among HIV-infected women, Atherosclerosis, 217, 207, 10.1016/j.atherosclerosis.2011.03.011 van Vonderen, 2009, Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy, J Infect Dis, 199, 1186, 10.1086/597475 Sevastianova, 2005, Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy, Antivir Ther, 10, 925, 10.1177/135965350501000808 Tabib, 2000, Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients, Coron Artery Dis, 11, 41, 10.1097/00019501-200002000-00008 Hsue, 2004, Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection, Circulation, 109, 316, 10.1161/01.CIR.0000114520.38748.AA Mintz, 2001, J Am Coll Cardiol, 37, 1478, 10.1016/S0735-1097(01)01175-5 Stone, 2011, A prospective natural-history study of coronary atherosclerosis, N Engl J Med, 364, 226, 10.1056/NEJMoa1002358 Bezerra, 2009, Intracoronary optical coherence tomography: a comprehensive review clinical and research applications, JACC Cardiovasc Interv, 2, 1035, 10.1016/j.jcin.2009.06.019 Kubo, 2007, Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy, J Am Coll Cardiol, 50, 933, 10.1016/j.jacc.2007.04.082 Raffel, 2007, Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography, Arterioscler Thromb Vasc Biol, 27, 1820, 10.1161/ATVBAHA.107.145987 Nadkarni, 2007, Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography, J Am Coll Cardiol, 49, 1474, 10.1016/j.jacc.2006.11.040 Lee, 2010, Temporal characterization of the functional density of the vasa vasorum by contrast-enhanced ultrasonography maximum intensity projection imaging, JACC Cardiovasc Imaging, 3, 1265, 10.1016/j.jcmg.2010.08.017 Madjid, 2006, Intracoronary thermography for detection of high-risk vulnerable plaques, J Am Coll Cardiol, 47, C80, 10.1016/j.jacc.2005.11.050 Caplan, 2006, Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques, J Am Coll Cardiol, 47, C92, 10.1016/j.jacc.2005.12.045 Waxman, 2009, In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study, JACC Cardiovasc Imaging, 2, 858, 10.1016/j.jcmg.2009.05.001 Larose, 2005, Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging, Circulation, 112, 2324, 10.1161/CIRCULATIONAHA.105.538942 Larose, 2008, Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries, Atherosclerosis, 196, 919, 10.1016/j.atherosclerosis.2007.02.020 Schaar, 2006, Intravascular palpography for vulnerable plaque assessment, J Am Coll Cardiol, 47, C86, 10.1016/j.jacc.2006.01.035 Fukumoto, 2008, Localized elevation of shear stress is related to coronary plaque rupture: a 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress distribution, J Am Coll Cardiol, 51, 645, 10.1016/j.jacc.2007.10.030 Sonne, 2005, Intravascular ultrasound-guided percutaneous coronary intervention in a human immunodeficiency virus-positive patient with cocaine-associated acute myocardial infarction: case report and review, Heart Lung Circ, 14, 197, 10.1016/j.hlc.2005.03.004 Rudd, 2002, Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography, Circulation, 105, 2708, 10.1161/01.CIR.0000020548.60110.76 Rudd, 2007, (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials, J Am Coll Cardiol, 50, 892, 10.1016/j.jacc.2007.05.024 Fifer, 2011, Positron emission tomography measurement of periodontal (18)f-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation, J Am Coll Cardiol, 57, 971, 10.1016/j.jacc.2010.09.056 Tahara, 2007, Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome, J Am Coll Cardiol, 49, 1533, 10.1016/j.jacc.2006.11.046 Tahara, 2006, Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography, J Am Coll Cardiol, 48, 1825, 10.1016/j.jacc.2006.03.069 Burdo T, Lo J, Wei J, et al. sCD163, a novel marker of activated macrophages, is associated with noncalcified coronary plaque in HIV patients. 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2011. Korosoglou, 2008, Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using “positive contrast” magnetic resonance imaging, J Am Coll Cardiol, 52, 483, 10.1016/j.jacc.2008.03.063 Tang, 2009, The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease, J Am Coll Cardiol, 53, 2039, 10.1016/j.jacc.2009.03.018 Burtea, 2008, Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA, Cardiovasc Res, 78, 148, 10.1093/cvr/cvm115